1. Semplicini A, Maresca
A, Monari A., Volpin A. Hypertension and diabetes.Hypertension letter,
1998;1-2:1-6 (IT)
2. Semplicini A, Maresca A. Acute stroke treatment. Hypertension and
cardiovascular prevention.1998;5:106-114 (IT)
3. Calò' L., Ceolotto G, Milani M, Pagnin E, Baritono E, Maresca
A, Bonfante L, Marcon R, Cantaro S, Semplicini A. Bartter e Gitelman’ syndromes vascular hyporeactivity. Italian Journal of Nephrology.2000;17:250-254
(IT)
4. A. Semplicini , A. Maresca, C. Simonella, C. Carollo, F. Chierichetti,
N. Santipolo, P. Pauletto, G. Ferlin, A. C. Pessina. Cerebral perfusion
in hypertensive patients: effects of lacidipine and hydrochlorotiazide.
Journal of Cardiovascular Pharmacology. 2000; 35 (suppl 1): S13-8
5. A. Semplicini , A. Maresca, C. Simonella, F. Chierichetti, P. Pauletto,
G. Meneghetti, G. Ferlin, A. C. Pessina. Cerebral perfusion in hypertensives
with carotid artery stenosis: a comparative study of lacidipine and
hydrochlorotiazide. Blood pressure 2000; 9 (1): 34-9
6. A. Semplicini, A. Maresca, M. Sartori, L. Calò. Hypertension
and cerebrovascular diseases: a specific role of vascular protection
in the prevention of dementia. Journal of Cardiovascular Pharmacology.
2001;38 (suppl. 2): S79-S82
7. A. Semplicini, A. Maresca, M. Sartori, R.Rocchi, E. Lanari, R.
Valente, G. Boscolo, L. Calò. Cerebral blood flow and hypertension.
Hypertension and cardiovascular 2001; 8(2): 55-59 (IT)
8. A. Semplicini, M. Sartori, A. Maresca, L. Calò. Ionic exchanges
in hypertension: role in the new millenium. Hypertension and cardiovascular
prevention 2001; 8(1):25-28 (IT)
9. A. Semplicini, G. Ceolotto, M. Sartori, A. Maresca, E. Baritono,
R. de Toni, I. Paparella, L. Calò. Regulation of glomerular
filtration in essential hypertension: role of abnormal Na+ transport
and atrial natriuretic peptide. J Nephrol 2002; 15(5): 489-96
10. GP Rossi, C. Ganzaroli, M. Cesari, A. Maresca, M. Plebani, GG
Nussdorfer, AC Pessina. Endothelin receptor blockade lowers plasma
aldosterone levels via different mechanisms in primary aldosteronism
and high-to–normal renin hypertension. Cardiovasc Res 2003;
57 (1): 277-83.
11. Semplicini A, Maresca A., Boscolo G, Sartori M, Rocchi R, Giantin
V, Forte PL, Pessina AC. Hypertension in acute stroke: a compensatory
mechanism or an additional damaging factor?. Archives of Internal
Medicine . 2003 vol. 163, pp. 211-216
12. AM Grandi, F. Solbiati, E. Laurita, E. Cassinerio, C. Marchesi,
F. Piperno, AM Maresca, L. Guasti, A. Venco. Isolated Office hypertension:
a 3 year follow-up study. Blood pressure. 2005; 14: 298-305
13. AM Grandi, AM Maresca, A. Sessa, R. Stella, D. Ponti, E. Barlocco,F.
Banfi, A. Venco Longitudinal Study on Hypertension Control in Primary
care: the Insubria Study American Journal of Hypertension, 2005, in
press
14. AM Grandi, AM Maresca et al. The metabolic syndrome influences
left ventricular mass and function in nondiabetic subjects. American
Journal of Hypertension. 2005, in press
15. AM Grandi, AM Maresca. Blockade of the renin-angiotensin-aldosterone
system: effects on hypertensive target organ damage. Current Medicinal
Chemistry- Cardiovascular and Hematological Agents 2005 in press
16. AM Grandi, E. Piantanida, I. Franzetti, M. Bernasconi, P. Marnini,
AM Maresca, L. Guasti, A. Venco.Glycemic control influences left ventricular
diastolic function in type 1 diabetes mellitus: a 12 month follow-up
study. American Journal of Cardiology, 2005 in press |